Download Content

TNFR2 And PD1 Resistance

Please enter your details into the form below to access the Webinar on ‘TNFR2 And PD1 Resistance‘. Hosted by Russell LaMontagne, Co-Founder and Chief Executive Officer, Boston Immune Technologies and Therapeutics.

Contact Form

Submit your details to register your interest & to be kept up to date about relevant events. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.